J Winiarski
Overview
Explore the profile of J Winiarski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
875
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilhelmsson M, Vatanen A, Borgstrom B, Gustafsson B, Taskinen M, Saarinen-Pihkala U, et al.
Bone Marrow Transplant
. 2015 Mar;
50(6):850-7.
PMID: 25798676
Treatment-related late toxicities after pediatric allogeneic hematopoietic SCT (allo-HSCT) are increasingly important as long-term survival has become an expected outcome for many transplanted children and adolescents. In a retrospective cohort...
2.
Vatanen A, Wilhelmsson M, Borgstrom B, Gustafsson B, Taskinen M, Saarinen-Pihkala U, et al.
Eur J Endocrinol
. 2013 Nov;
170(2):211-8.
PMID: 24179099
Objective: The aim of the study was to evaluate long-term ovarian function after allogeneic hematopoietic stem cell transplantation (HSCT) in childhood and adolescence. Subjects And Methods: Predictive factors for ovarian...
3.
Carlsson G, Winiarski J, Ljungman P, Ringden O, Mattsson J, Nordenskjold M, et al.
Pediatr Blood Cancer
. 2010 Nov;
56(3):444-51.
PMID: 21072829
Background: Severe congenital neutropenia (SCN) is an immunodeficiency characterized by disturbed myelopoiesis and an absolute neutrophil count (ANC) <0.5 × 10(9)/L. SCN is also a premalignant condition; a significant proportion...
4.
Rubin J, Vettenranta K, Vettenranta J, Bierings M, Abrahamsson J, Bekassy A, et al.
Bone Marrow Transplant
. 2010 May;
46(3):372-8.
PMID: 20498650
Conflicting conclusions can be drawn from the available data concerning antileukemic efficacy and risks of intrathecal (i.t.) chemoprophylaxis to children after hematopoietic SCT (HSCT). To address this, we enrolled six...
5.
Omar H, Hagglund H, Gustafsson-Jernberg A, LeBlanc K, Mattsson J, Remberger M, et al.
Transpl Infect Dis
. 2009 Jun;
11(5):393-9.
PMID: 19497070
Background: Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disease (PTLD) is a serious complication after allogeneic stem cell transplantation (SCT). The likelihood of PTLD is increased in the presence of specific risk...
6.
Lof C, Winiarski J, Giesecke A, Ljungman P, Forinder U
Bone Marrow Transplant
. 2008 Oct;
43(6):461-8.
PMID: 18936733
Fifty-three adults who had received SCT as children responded to questionnaires on health-related quality of life (HRQoL) (Swedish HRQoL survey (SWED-QUAL)), sense of coherence (SOC), anxiety and depression (HAD) and...
7.
Smedler A, Winiarski J
Bone Marrow Transplant
. 2008 Aug;
42(8):515-22.
PMID: 18679374
Stem cell transplantation involves conditioning with TBI and/or intensive chemotherapy, which may cause long-term neuropsychological deficits, particularly in children treated at a very young age. The aim of this study...
8.
Giraud G, Priftakis P, Bogdanovic G, Remberger M, DUBRULLE M, Hau A, et al.
Bone Marrow Transplant
. 2008 Jan;
41(8):737-42.
PMID: 18176615
The influence of conditioning regimen, donor background and HLA matching on development of BK virus (BKV)-associated haemorrhagic cystitis (HC) was examined in 175 allogeneic haematopoietic stem cell transplant (HSCT) patients,...
9.
Mellgren K, Nilsson C, Fasth A, Abrahamsson J, Winiarski J, Ringden O, et al.
Bone Marrow Transplant
. 2007 Dec;
41(7):621-5.
PMID: 18084338
We compared outcome and toxicity in two paediatric groups undergoing SCT and treated with busulphan (BU) by the oral route of administration. One group receiving the standard dose of 1...
10.
Bjorklund A, Aschan J, Labopin M, Remberger M, Ringden O, Winiarski J, et al.
Bone Marrow Transplant
. 2007 Sep;
40(11):1055-62.
PMID: 17891187
Infectious complications remain a major problem contributing to significant mortality after hematopoietic allogeneic stem cell transplantation (HSCT). Few studies have previously analyzed mortality due to late infections. Forty-four patients dying...